In Treg cell activation, both CD45 negative and positive EVs derived from plasma in head and neck cancer induced Treg differentiation of CD4 cells, but CD45(-) EVs also reduced CD8+ T-cell activation due to their higher adenosine concentrations [174]. This evidence concerns the gene PTPRC and head and neck cancer.